Richard H Carmona
CIK 1389349 · last filed 2026-05-12
Richard H Carmona is a corporate insider who has filed 58 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing, for HLF, was dated May 12, 2026. Across all open-market trades the lifetime net is −$9.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$11.54M
6
58
-$9.77M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HLF | Director | 83,645 | $12.54 | $1.05M | -$555.0K | 16 | 2026-05-12 |
| MCK | Director | — | $889.50 | — | $0 | 4 | 2024-08-01 |
| Better Therapeutics, Inc. (BTTX) Delisted | Director | 157,369 | $0.04 | $7.0K | $0 | 4 | 2023-12-20 |
| CLX | Director | — | $100.32 | — | $0 | 15 | 2022-01-04 |
| AXON | Director | 19,162 | $547.65 | $10.49M | $0 | 1 | 2021-06-01 |
| AXON ENTERPRISE, INC. (AAXN) Delisted | Director | 17,728 | — | — | -$9.22M | 9 | 2020-06-02 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-12 | HLF | Grant (A) | +11,879 | $0 | EDGAR |
| 2025-05-06 | HLF | Grant (A) | +21,857 | $0 | EDGAR |
| 2024-08-01 | MCK | Grant (A) | — | $0 | EDGAR |
| 2024-05-07 | HLF | Grant (A) | +15,657 | $0 | EDGAR |
| 2023-12-20 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | +3,750 | $0 | EDGAR |
| 2023-07-25 | MCK | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-08 | HLF | Grant (A) | +11,029 | $0 | EDGAR |
| 2022-07-26 | MCK | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | Better Therapeutics, Inc. (BTTX) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.